Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARATUMUMAB\HYALURONIDASE-FIHJ for Plasma cell myeloma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,092 adverse event reports in the FDA FAERS database where DARATUMUMAB\HYALURONIDASE-FIHJ was used for Plasma cell myeloma.

Most Reported Side Effects for DARATUMUMAB\HYALURONIDASE-FIHJ

Side Effect Reports % Deaths Hosp.
Product dose omission issue 189 7.4% 0 10
Dyspnoea 112 4.4% 9 50
Off label use 109 4.3% 9 18
Fatigue 101 4.0% 3 30
Pyrexia 86 3.4% 3 44
Nausea 80 3.2% 2 33
Pneumonia 78 3.1% 8 59
Plasma cell myeloma 74 2.9% 13 9
Diarrhoea 71 2.8% 6 27
Neutropenia 70 2.8% 5 16
Infusion related reaction 66 2.6% 6 28
Rash 65 2.6% 0 9
Chills 63 2.5% 0 12
Neuropathy peripheral 62 2.4% 2 10
Death 61 2.4% 61 9

Other Indications for DARATUMUMAB\HYALURONIDASE-FIHJ

Product used for unknown indication (930) Primary amyloidosis (44) Amyloidosis (31) Plasma cell myeloma refractory (19) Plasma cell myeloma recurrent (10)

Other Drugs Used for Plasma cell myeloma

LENALIDOMIDE (273,951) POMALIDOMIDE (81,096) DEXAMETHASONE (49,067) BORTEZOMIB (31,567) DARATUMUMAB (19,119) IXAZOMIB (17,602) CARFILZOMIB (15,333) THALIDOMIDE (10,689) CYCLOPHOSPHAMIDE (9,148) REVLIMID (7,122)

Related Pages

DARATUMUMAB\HYALURONIDASE-FIHJ Full Profile All Plasma cell myeloma Drugs DARATUMUMAB\HYALURONIDASE-FIHJ Demographics DARATUMUMAB\HYALURONIDASE-FIHJ Timeline